BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 16679021)

  • 1. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size.
    Ruvinsky I; Meyuhas O
    Trends Biochem Sci; 2006 Jun; 31(6):342-8. PubMed ID: 16679021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribosomal protein S6 kinase from TOP mRNAs to cell size.
    Meyuhas O; Dreazen A
    Prog Mol Biol Transl Sci; 2009; 90():109-53. PubMed ID: 20374740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mTOR signaling pathway mediates control of ribosomal protein mRNA translation in rat liver.
    Reiter AK; Anthony TG; Anthony JC; Jefferson LS; Kimball SR
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2169-79. PubMed ID: 15313464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raptor-rictor axis in TGFbeta-induced protein synthesis.
    Das F; Ghosh-Choudhury N; Mahimainathan L; Venkatesan B; Feliers D; Riley DJ; Kasinath BS; Choudhury GG
    Cell Signal; 2008 Feb; 20(2):409-23. PubMed ID: 18068336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR.
    Williamson DL; Bolster DR; Kimball SR; Jefferson LS
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E80-9. PubMed ID: 16760336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosomal S6 kinase signaling and the control of translation.
    Dufner A; Thomas G
    Exp Cell Res; 1999 Nov; 253(1):100-9. PubMed ID: 10579915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an activated ribosomal S6 kinase variant from maturing sea star oocytes: association with phosphatase 2A and substrate specificity.
    Charlton LA; Sayed M; Clark-Lewis I; Aebersold R; Pelech SL
    J Cell Biochem; 1999 Nov; 75(2):310-26. PubMed ID: 10502303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX; Yang X; Sreejayan N; Ren J
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis.
    Ruvinsky I; Sharon N; Lerer T; Cohen H; Stolovich-Rain M; Nir T; Dor Y; Zisman P; Meyuhas O
    Genes Dev; 2005 Sep; 19(18):2199-211. PubMed ID: 16166381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli.
    Eley HL; Russell ST; Baxter JH; Mukerji P; Tisdale MJ
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E923-31. PubMed ID: 17609254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When translation meets transformation: the mTOR story.
    Averous J; Proud CG
    Oncogene; 2006 Oct; 25(48):6423-35. PubMed ID: 17041627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenesis and protein synthesis: a role for ribosomal protein S6 phosphorylation?
    Stewart MJ; Thomas G
    Bioessays; 1994 Nov; 16(11):809-15. PubMed ID: 7840758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth.
    Yang X; Yang C; Farberman A; Rideout TC; de Lange CF; France J; Fan MZ
    J Anim Sci; 2008 Apr; 86(14 Suppl):E36-50. PubMed ID: 17998426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheb activation of mTOR and S6K1 signaling.
    Hanrahan J; Blenis J
    Methods Enzymol; 2006; 407():542-55. PubMed ID: 16757352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upstream and downstream of mTOR.
    Hay N; Sonenberg N
    Genes Dev; 2004 Aug; 18(16):1926-45. PubMed ID: 15314020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
    Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
    J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.
    Gao XM; Wong G; Wang B; Kiriazis H; Moore XL; Su YD; Dart A; Du XJ
    J Hypertens; 2006 Aug; 24(8):1663-70. PubMed ID: 16877971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O; Almazan G
    J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenaline enhances the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of PI3K/Akt and the mTOR/S6K pathway.
    Chenal J; Pellerin L
    J Neurochem; 2007 Jul; 102(2):389-97. PubMed ID: 17394554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific interaction between S6K1 and CoA synthase: a potential link between the mTOR/S6K pathway, CoA biosynthesis and energy metabolism.
    Nemazanyy I; Panasyuk G; Zhyvoloup A; Panayotou G; Gout IT; Filonenko V
    FEBS Lett; 2004 Dec; 578(3):357-62. PubMed ID: 15589845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.